Absci | Investor Presentation Deck | 48 slides · page 14 of 48
The slide highlights the efficacy of the company's de novo design model by comparing it against a known benchmark (trastuzumab).
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 image 1/1 list 1/1 paragraph 1/1 title 2/2
Components 6
histogram illustration bullet paragraph action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.